Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

9.89
Delayed Data
As of Mar 05
 +0.43 / +4.55%
Today’s Change
7.09
Today|||52-Week Range
11.47
+19.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2010

2011

2012

2013
Operating ActivitiesNet Income / Starting Line-38.5M53.8M-46.3M-92.3M
 
 
 
 
 
Depreciation1.2M879.0K871.0K742.0K
 
 
 
 
 
Total Other Cash Flow-1.1M-91.1M983.0K28.3M
 
 
 
 
 
Funds From Operations-38.4M-36.4M-44.0M-63.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-5.9M-188.0K3.2M-5.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-32.5M-36.2M-47.2M-57.9M
 
 
 
 
 
 
InvestingIncrease In Investments-32.8M-17.9M-97.7M-85.6M
 
 
 
 
 
Decrease In Investments58.9M26.9M49.5M75.8M
 
 
 
 
 
Capital Expenditures-294.0K-685.0K-753.0K-1.6M
 
 
 
 
 
Other Investing - Sources0.0025.6M0.000.00
 
 
Net Cash Flow Investing25.8M33.9M-49.0M-12.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.0029.0M-6.0M86.4M
 
 
 
 
Long Term Debt Reduction0.000.00-6.8M-24.3M
 
 
 
Net Proceeds Stock Sale4.0K29.0K100.7M2.4M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing397.0K0.000.000.00
 
 
Other Uses - Financing1.3M2.0M0.001.7M
 
 
 
 
Net Cash Flow - Financing-944.0K27.1M87.9M62.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash-7.7M24.8M-8.2M-7.3M
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account